• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用生物制剂治疗银屑病相关的潜在并发症。

Potential complications associated with the use of biologic agents for psoriasis.

作者信息

Zeichner Joshua A, Lebwohl Mark

机构信息

Department of Dermatology, Mount Sinai Medical Center, 5 East 98th Street, Box 1048, New York, NY 10029, USA.

出版信息

Dermatol Clin. 2007 Apr;25(2):207-13, vii. doi: 10.1016/j.det.2007.01.010.

DOI:10.1016/j.det.2007.01.010
PMID:17430757
Abstract

The biologic agents are effective drugs to treat psoriasis. They provide physicians with additional options for patients who cannot tolerate traditional therapies or for whom traditional therapies are not sufficient. While these new TNF-alpha inhibitors and anti-T-cell agents have potential complications, they are generally safe with proper monitoring. Both physicians and patients should be aware of the risks involved with each medicine so that the correct drug is chosen to suit each patient.

摘要

生物制剂是治疗银屑病的有效药物。它们为那些无法耐受传统疗法或传统疗法效果不佳的患者提供了更多选择。虽然这些新型肿瘤坏死因子-α抑制剂和抗T细胞药物存在潜在并发症,但在适当监测下总体是安全的。医生和患者都应了解每种药物所涉及的风险,以便选择适合每位患者的正确药物。

相似文献

1
Potential complications associated with the use of biologic agents for psoriasis.使用生物制剂治疗银屑病相关的潜在并发症。
Dermatol Clin. 2007 Apr;25(2):207-13, vii. doi: 10.1016/j.det.2007.01.010.
2
[Infectious risk].[感染风险]
Actas Dermosifiliogr. 2008 Jul;99 Suppl 4:14-22.
3
How to manage infections in the era of biologics?在生物制剂时代如何管理感染?
Dermatol Ther. 2008 May-Jun;21(3):180-6. doi: 10.1111/j.1529-8019.2008.00189.x.
4
Infliximab associated new-onset psoriasis.
J Drugs Dermatol. 2006 Feb;5(2):178-9.
5
Autoimmunity by anti-tumour necrosis factor-alpha agents: the role of traditional therapies.抗肿瘤坏死因子-α药物引起的自身免疫:传统疗法的作用
J Eur Acad Dermatol Venereol. 2010 Mar;24(3):356-7. doi: 10.1111/j.1468-3083.2009.03386.x. Epub 2009 Aug 16.
6
Gastric MALT lymphoma in a patient receiving infliximab for psoriasis.一名接受英夫利昔单抗治疗银屑病的患者发生胃黏膜相关淋巴组织淋巴瘤。
Br J Dermatol. 2008 Aug;159(2):497-8. doi: 10.1111/j.1365-2133.2008.08664.x. Epub 2008 Jun 28.
7
Autoimmune hepatitis associated with infliximab in a patient with palmoplantar pustular psoriaisis.一名掌跖脓疱型银屑病患者中与英夫利昔单抗相关的自身免疫性肝炎。
Clin Exp Dermatol. 2009 Apr;34(3):421-2. doi: 10.1111/j.1365-2230.2008.03088.x.
8
[Multiple lesions of focal cutaneous mucinosis: a side-effect of anti-TNF alpha therapy?].
Ann Dermatol Venereol. 2010 Feb;137(2):140-2. doi: 10.1016/j.annder.2010.01.001. Epub 2010 Jan 29.
9
New Therapies for Psoriasis.银屑病的新疗法
Semin Cutan Med Surg. 2016 Jun;35(4 Suppl 4):S71-3. doi: 10.12788/j.sder.2016.021.
10
Recent advances in medical dermatology.
Int J Dermatol. 2007 Oct;46(10):1005-10. doi: 10.1111/j.1365-4632.2007.03235.x.

引用本文的文献

1
Treating Generalized Pustular Psoriasis (GPP): Timing and Rationale for Biologic Treatment Switching-A Japanese e-Delphi Survey.治疗泛发性脓疱型银屑病(GPP):生物治疗转换的时机与理论依据——一项日本电子德尔菲调查
Dermatol Ther (Heidelb). 2025 Apr;15(4):1009-1024. doi: 10.1007/s13555-025-01377-3. Epub 2025 Mar 22.
2
Current knowledge on psoriasis and autoimmune diseases.关于银屑病和自身免疫性疾病的现有知识。
Psoriasis (Auckl). 2016 Feb 22;6:7-32. doi: 10.2147/PTT.S64950. eCollection 2016.
3
Burden of Moderate-to-Severe Plaque Psoriasis and New Therapeutic Approaches (Secukinumab): An Italian Perspective.
中重度斑块状银屑病的负担与新治疗方法(司库奇尤单抗):意大利视角
Dermatol Ther (Heidelb). 2016 Jun;6(2):151-67. doi: 10.1007/s13555-016-0114-9. Epub 2016 Apr 15.
4
Evaluation of renal function in patients with psoriasis using immunobiologicals.使用免疫生物制剂评估银屑病患者的肾功能。
An Bras Dermatol. 2013 Jul-Aug;88(4):667-9. doi: 10.1590/abd1806-4841.20132035.
5
A practical approach to screening psoriasis patients for therapy with biologic agents.一种筛查银屑病患者以使用生物制剂进行治疗的实用方法。
J Clin Aesthet Dermatol. 2008 Sep;1(3):50-4.
6
A practical approach to monitoring patients on biological agents for the treatment of psoriasis.一种监测接受生物制剂治疗银屑病患者的实用方法。
J Clin Aesthet Dermatol. 2010 Aug;3(8):20-6.
7
A role for TGFbeta signaling in the pathogenesis of psoriasis.TGFβ 信号在银屑病发病机制中的作用。
J Invest Dermatol. 2010 Feb;130(2):371-7. doi: 10.1038/jid.2009.252. Epub 2009 Aug 27.
8
Biological drugs targeting the immune response in the therapy of psoriasis.用于银屑病治疗的针对免疫反应的生物药物。
Biologics. 2008 Dec;2(4):687-97. doi: 10.2147/btt.s2763.